Omega Therapeutics Dirección
Dirección controles de criterios 0/4
Información clave
Mahesh Karande
Chief Executive Officer (CEO)
US$1.7m
Compensación total
| Porcentaje del salario del CEO | 34.5% |
| Permanencia del CEO | 5yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | less than a year |
| Promedio de permanencia en la Junta Directiva | 3.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'
Mar 31Is Omega Therapeutics (NASDAQ:OMGA) Weighed On By Its Debt Load?
Feb 28
Omega Therapeutics: The Next Weight Loss Drug Runner
Jan 16Omega Therapeutics: Starting 2024 With A Bang
Jan 10Omega Therapeutics GAAP EPS of -$0.54 in-line, revenue of $0.48M beats by $0.43M
Aug 04Omega Therapeutics gets FDA nod to start liver cancer trial of lead drug OTX-2002
Jul 14Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$92m |
| Dec 31 2023 | US$2m | US$579k | -US$97m |
| Sep 30 2023 | n/a | n/a | -US$108m |
| Jun 30 2023 | n/a | n/a | -US$112m |
| Mar 31 2023 | n/a | n/a | -US$108m |
| Dec 31 2022 | US$4m | US$556k | -US$103m |
| Sep 30 2022 | n/a | n/a | -US$93m |
| Jun 30 2022 | n/a | n/a | -US$85m |
| Mar 31 2022 | n/a | n/a | -US$75m |
| Dec 31 2021 | US$5m | US$512k | -US$68m |
| Sep 30 2021 | n/a | n/a | -US$57m |
| Jun 30 2021 | n/a | n/a | -US$47m |
| Mar 31 2021 | n/a | n/a | -US$38m |
| Dec 31 2020 | US$939k | US$483k | -US$29m |
CEO
Mahesh Karande (50 yo)
5yrs
Permanencia
US$1,675,727
Compensación
Mr. Mahesh Karande serves as Director of Ashvattha Therapeutics, Inc. from May 2023. He serves as Director at KSQ Therapeutics, Inc. since December 2022. He serves as President, Chief Executive Officer and...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5yrs | US$1.68m | 0.21% $ 218.9k | |
| Principal Financial Office | less than a year | sin datos | 0.068% $ 70.1k | |
| Chief Scientific Officer | 4.9yrs | US$1.32m | sin datos | |
| Senior Vice President of Investor Relations & Corporate Affairs | less than a year | sin datos | sin datos | |
| Chief People Officer | 1.4yrs | sin datos | sin datos | |
| VP and Head of Computational Genomics & Data Sciences | 2.8yrs | sin datos | sin datos | |
| Chief Business Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Clinical Development Operations | less than a year | sin datos | sin datos |
0.9yrs
Permanencia media
55yo
Promedio de edad
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5yrs | US$1.68m | 0.21% $ 218.9k | |
| Independent Director | 4.4yrs | US$151.29k | 0% $ 0 | |
| Independent Chairman of Board | less than a year | US$135.55k | 0% $ 0 | |
| Independent Director & Scientific Advisor | 6.8yrs | US$265.18k | 1.34% $ 1.4m | |
| Independent Director | 3.1yrs | US$151.18k | 0% $ 0 | |
| Independent Director | 5yrs | US$153.68k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$148.68k | 0% $ 0 | |
| Scientific Advisor | no data | sin datos | sin datos | |
| Independent Director | 3.3yrs | US$149.19k | 0% $ 0 | |
| Independent Director | less than a year | US$97.51k | 0% $ 0 |
3.3yrs
Permanencia media
64yo